The Value of Periodic Follow-up in the Detection of Recurrences after Radical Treatment in Locally Advanced Head and Neck Cancer

Clinical Oncology

Volumn 22, Issue 10, 2010, Pages 868-873

  Flynn, C J ^a   Khaouam, N ^b   Gardner, S ^a   Higgins, K ^a   Enepekides, D ^a   Balogh, J ^a   MacKenzie, R ^a   Singh, S ^a   Davidson, J ^a   Poon, I ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

Follow up; Head and neck cancer; Squamous cell carcinoma; Tumour recurrence; Value

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATHOLOGY; PERINEURIUM; PERIODIC MEDICAL EXAMINATION; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGIONAL METASTASIS; RETROSPECTIVE STUDY; SALVAGE THERAPY; SELF EVALUATION; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78149501351     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.05.016     Document Type: Article

References (36)

1. Grau J.J., Cuchi A., Traserra J., et al. Follow-up study in head and neck cancer: cure rate according to tumor location and stage. Oncology 1997, 54(1):38-42.
2. Cooney T.R., Poulsen M.G. Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer?. Arch Otolaryngol Head Neck Surg 1999, 125(4):379-382.
3. Boysen M., Lovdal O., Tausjo J., Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992, 28(2-3):426-430.
4. de Visscher A.V., Manni J.J. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense?. Arch Otolaryngol Head Neck Surg 1994, 120(9):934-939.
5. Sturgis E.M., Miller R.H. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995, 104(12):946-954.
6. Ritoe S.C., Krabbe P.F., Kaanders J.H., van den Hoogen F.J., Verbeek A.L., Marres H.A. Value of routine follow-up for patients cured of laryngeal carcinoma. Cancer 2004, 101(6):1382-1389.
7. Broyn T., Froyen J. Evaluation of routine follow-up after surgery for breast carcinoma. Acta Chir Scand 1982, 148(5):401-404.
8. Dewar J.A., Kerr G.R. Value of routine follow up of women treated for early carcinoma of the breast. Br Med J (Clin Res Ed) 1985, 291(6507):1464-1467.
9. Kolb E., Buchmann P. Experience with long-term studies of patients after radical surgery for bronchial carcinoma. Schweiz Rundsch Med Prax 1985, 74(38):1017-1019. [German].
10. Cochrane J.P., Williams J.T., Faber R.G., Slack W.W. Value of outpatient follow-up after curative surgery for carcinoma of the large bowel. Br Med J 1980, 280(6214):593-595.
11. Ekman C.A., Gustavson J., Henning A. Value of a follow-up study of recurrent carcinoma of the colon and rectum. Surg Gynecol Obstet 1977, 145(6):895-897.
12. Wolfensberger M. Consumption and value of regular after care by patients with squamous cell carcinomas of the larynx, mouth cavity and pharynx. HNO 1988, 36(1):28-32. [German].
13. Saussez S., Dekeyser C., Thill M.P., Chantrain G. Importance of clinical and radiological follow-up in head and neck cancers. B-ENT 2007, 3(4):179-184.
14. Merkx M.A., van Gulick J.J., Marres H.A., et al. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue. Head Neck 2006, 28(1):1-7.
15. Snow G.B. Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for how long?. Eur J Cancer 1992, 28(2-3):315-316.
16. Lawless J.F. Statistical models and methods for lifetime data 1982, John Wiley & Sons, New York, NY.
17. Pintilie M. Competing risks: a practical perspective 2006, John Wiley & Sons, New York, NY.
18. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging manual 2002, Springer, New York. 6th ed.
19. Watanabe A., Taniguchi M., Tsujie H., Hosokawa M., Fujita M., Sasaki S. The value of narrow band imaging endoscope for early head and neck cancers. Otolaryngol Head Neck Surg 2008, 138(4):446-451.
20. van den Broek F.J., Reitsma J.B., Curvers W.L., Fockens P., Dekker E. Systematic review of narrow-band imaging for the detection and differentiation of neoplastic and nonneoplastic lesions in the colon (with videos). Gastrointest Endosc 2009, 69(1):124-135.
21. Lee M.M., Enns R. Narrow band imaging for the detection of neoplastic lesions of the colon. Can J Gastroenterol 2009, 23(1):15-18.
22. Goldberg R.M., Fleming T.R., Tangen C.M., et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Centre Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998, 129(1):27-35.
23. Graham R.A., Wang S., Catalano P.J., Haller D.G. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest X-ray, and colonoscopy. Ann Surg 1998, 228(1):59-63.
24. de-Vathaire F., Sancho-Garnier H., de-Thé H., et al. Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study. Int J Cancer 1988, 42(2):176-181.
25. Liu M.T., Yeh C.Y. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC). Radiat Med 1998, 16(2):113-117.
26. Kumar B., Cordell K.G., Lee J.S., et al. Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys 2007, 69(2 Suppl.):S109-S111.
27. Chung Y.L., Lee M.Y., Horng C.F. Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone. Head Neck 2009, 31(1):9-20.
28. Reeve H., Baxter K., Newton P., Burkey Y., Black M., Roland M. Long-term follow-up in outpatient clinics. 1: the view from general practice. Fam Pract 1997, 14(1):24-28.
29. Burkey Y., Black M., Reeve H., Roland M. Long-term follow-up in outpatient clinics. 2: the view from the specialist clinic. Fam Pract 1997, 14(1):29-33.
30. Chait I., Glynne-Jones R., Thomas S. A pilot study exploring the effect of discharging cancer survivors from hospital follow-up on the workload of general practitioners. Br J Gen Pract 1998, 48(430):1241-1243.
31. Vanhuyse M., Bedard P.L., Sheiner J., Fitzgerald B., Clemons M. Transfer of follow-up care to family physicians for early-stage breast cancer. Clin Oncol (R Coll Radiol) 2007, 19(3):172-176.
32. Grunfeld E., Fitzpatrick R., Mant D., et al. Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 1999, 49(446):705-710.
33. Grunfeld E., Gray A., Mant D., et al. Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation. Br J Cancer 1999, 79(7-8):1227-1233.
34. Gabriel G.S., Lah M., Barton M., Au G., Delaney G., Jalaludin B. Do cancer follow-up consultations create anxiety?. J Psychosoc Oncol 2008, 26(1):17-30.
35. Sheppard C. Breast cancer follow-up: literature review and discussion. Eur J Oncol Nurs 2007, 11(4):340-347.
36. Li Destri G., Sapienza S., Rodolico M., et al. Stress of routine follow-up in colorectal cancer operated patients. Chir Ital 2000, 52(6):695-698.